Skip to main content
OpenTrials

Clinical trial condition

Influenza, Human

Explore clinical trials studying Influenza, Human. Study availability and eligibility vary by location and protocol.

190 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Influenza, Human trial results

Completed

A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine

NCT04669691

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • 23302- Al Mare Perearstikeskus OÜ Tallinn, Harju, Estonia
  • 23301- Clinical Research Center Tartu, Estonia
  • 60805 - De La Salle Medical and Health Sciences Institute Dasmariñas, Manila, Philippines
  • 60804 - University of Perpetual Help Dalta Medical Center Las Piñas, Manila, Philippines
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

NCT05052697

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • North Alabama Research Center Athens, Alabama, United States
  • The Heart Center Athens, Alabama, United States
  • Arizona Heart Rhythm Center Phoenix, Arizona, United States
  • HOPE Research Institute Phoenix, Arizona, United States
View all 100 locations
View Trial Details
Completed

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

NCT05981846

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +12 more
Locations
  • Hospital Clínico Universitario de Santiago Santiago de Compostela, A Coruña, Spain
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • CAP Centelles Centelles, Barcelona, Spain
  • Hospital HM Modelo A Coruña, Spain
View Trial Details
Completed

Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season

NCT03688620

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Leuven, Belgium
  • GSK Investigational Site Steenokkerzeel, Belgium
  • GSK Investigational Site Tessenderlo, Belgium
  • GSK Investigational Site Dachau, Bavaria, Germany
View Trial Details
Completed

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older

NCT04789577

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Stockbridge, Georgia, United States
  • GSK Investigational Site Meridian, Idaho, United States
  • GSK Investigational Site Cary, North Carolina, United States
  • GSK Investigational Site Wilmington, North Carolina, United States
View Trial Details
Completed

A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age

NCT05044195

Conditions
Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations
  • 84013 Coastal Clinical Research, Inc. Mobile, Alabama, United States
  • 84007 Alliance for Multispecialty Research Tempe, Arizona, United States
  • 84005 JEM Research Institute Atlantis, Florida, United States
  • 84010 Headlands Research Orlando Orlando, Florida, United States
View all 29 locations
View Trial Details
Completed

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

NCT05269290

Conditions
Acute Respiratory Infection, Common Cold, Infections, +7 more
Locations
  • Federal Research and Clinical Center of Physical and Chemical Medicine of the Federal Medical and Biological Agency Odintsovo, Moscow Oblast, Russia
  • City Pediatric Outpatient Clinic number 5 Perm, Russia
  • Professors' Clinic LLC. Perm, Russia
  • St. Petersburg State Budgetary Healthcare Institution "Children's City Polyclinic No. 44" Saint Petersburg, Russia
View Trial Details

Related conditions